American Journal of Obstetrics & Gynecology
Volume 202, Issue 6 , Pages 561.e1-561.e5 , June 2010

Placental vascular lesion differences in pregnancy-induced hypertension and normotensive fetal growth restriction

Presented at the 29th Annual Scientific Meeting of the Society for Maternal-Fetal Medicine, San Diego, CA, Jan. 26-31, 2009.

  • Michal Kovo, MD, PhD

      Affiliations

    • Departments of Obstetrics and Gynecology, Edith Wolfson Medical Center, Holon, Israel
    • Corresponding Author InformationReprints: Michal Kovo, MD, PhD, Department of Obstetrics & Gynecology, The Edith Wolfson Medical Center, PO Box 5, Holon 58100, Israel
  • ,
  • Letizia Schreiber, MD

      Affiliations

    • Department of Pathology, Edith Wolfson Medical Center, Holon, Israel
  • ,
  • Avi Ben-Haroush, MD

      Affiliations

    • Rabin Medical Center, Petah-Tikva, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
  • ,
  • Suzanna Wand, MD

      Affiliations

    • Departments of Obstetrics and Gynecology, Edith Wolfson Medical Center, Holon, Israel
  • ,
  • Abraham Golan, MD

      Affiliations

    • Departments of Obstetrics and Gynecology, Edith Wolfson Medical Center, Holon, Israel
  • ,
  • Jacob Bar, MD, MSc

      Affiliations

    • Departments of Obstetrics and Gynecology, Edith Wolfson Medical Center, Holon, Israel

Received 12 July 2009 ,Revised 20 October 2009 ,Accepted 12 January 2010.

References 

  1. Mari G, Hanif F. Intrauterine growth restriction: how to manage and when to deliver. Clin Obstet Gynecol. 2007;50:497–509
  2. Maynard SE, Venkatesh S, Thadhani R, Karumanchi SA. Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia. Pediatr Res. 2005;57:1R–7R
  3. Levine RJ, Karumanchi SA. Circulating angiogenic factors in preeclampsia. Clin Obstet Gynecol. 2005;48:372–386
  4. Kinzler WL, Vintzileos AM. Fetal growth restriction: a modern approach. Curr Opin Obstet Gynecol. 2008;20:125–131
  5. Chaddha V, Viero S, Huppertz B, Kingdom J. Developmental biology of the placenta and the origins of placental insufficiency. Semin Fetal Neonatal Med. 2004;9:357–369
  6. Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009;30(suppl A):S32–S37
  7. Redline RW, Heler D, Keating S, Kingdom J. Placental diagnostic criteria and clinical correlation: a workshop report. Placenta. 2005;26(suppl A):S114–S117
  8. Redline RW. Placental pathology: a systematic approach with clinical correlations. Placenta. 2008;29(suppl A):S86–S91
  9. Salafia CM, Pezzullo JC, Ghidini A, Lopez-Zeno JA, Whittington SS. Clinical correlations of patterns of placental pathology in preterm pre-eclampsia. Placenta. 1998;19:67–72
  10. Sebire NJ, Goldin RD, Regan L. Term preeclampsia is associated with minimal histopathological placental features regardless of clinical severity. J Obstet Gynaecol. 2005;25:117–118
  11. Vinnars MT, Wijnaendts LC, Westgren M, Bolte AC, Papadogiannakis N, Nasiell J. Severe preeclampsia with and without HELLP differ with regard to placental pathology. Hypertension. 2008;51:1295–1299
  12. Roberts DJ, Post MD. The placenta in pre-eclampsia and intrauterine growth restriction. J Clin Pathol. 2008;61:1254–1260
  13. Roberts D, Schwartz RS. Clotting and hemorrhage in the placenta: a delicate balance. N Engl J Med. 2002;347:57–59
  14. Dollberg M, Haklai Z, Mimouni FB, Gorfein I, Gordon ES. Birth weight standards in the live-born population in Israel. IMA J Math Appl Med Biol. 2005;7:311–314
  15. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183:S1–S22
  16. Stocker TJ, Dehner LP. Pediatric pathology, vol 2. Philadelphia, PA: Lippincott Williams & Wilkins; 2002;
  17. Mayhew TM, Ohadike C, Baker PN, Crocker IP, Mitchell C, Ong SS. Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. Placenta. 2003;24:219–226
  18. Zhang P, Schmidt M, Cook L. Maternal vasculopathy and histologic diagnosis of preeclampsia: poor correlation of histologic changes and clinical manifestation. Am J Obstet Gynecol. 2006;194:1050–1056
  19. Redline RW, Boyd T, Campbell V, et al. Maternal vascular underperfusion: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol. 2004;7:237–249
  20. Hansen AR, Collins MH, Genest D, et al. Very low birthweight Infant's placenta and its relation to pregnancy and fetal characteristics. Pediatr Dev Pathol. 2000;3:419–430
  21. Tyson RW, Staat BC. The intrauterine growth-restricted fetus and placenta evaluation. Semin Perinatol. 2008;32:166–171
  22. Srinivas SK, Ernst LM, Edlow AG, Elovitz MA. Can placental pathology explain second-trimester pregnancy loss and subsequent pregnancy outcomes?. Am J Obstet Gynecol. 2008;199:402.e1-5
  23. Redline RW, Ariel I, Baergen RN, et al. Fetal vascular obstructive lesions: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol. 2004;7:443–452
  24. Redline RW. Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum Pathol. 2007;38:1439–1446
  25. Salafia CM, Charles AK, Maas EM. Placenta and fetal growth restriction. Clin Obstet Gynecol. 2006;49:236–256
  26. Correa RR, Gilio DB, Cavellani CL, et al. Placental morphometrical and histopathology changes in the different clinical presentations of hypertensive syndromes in pregnancy. Arch Gynecol Obstet. 2008;277:201–206
  27. Altshuler G, Russell P, Ermocilla R. The placental pathology of small-for-gestational age infants. Am J Obstet Gynecol. 1975;121:351–359
  28. Labarrere C, Althabe O, Telenta M. Chronic villitis of unknown aetiology in placentae of idiopathic small for gestational age infants. Placenta. 1982;3:309–317
  29. Salafia CM, Vintzileos AM, Silberman L, Bantham KF, Vogel CA. Placental pathology of idiopathic intrauterine growth retardation at term. Am J Perinatol. 1992;9:179–184
  30. Gruenwald P. Abnormalities of placental vascularity in relation to intrauterine deprivation and retardation of fetal growth (Significance of avascular chorionic villi). N Y State J Med. 1961;61:1508–1513
  31. Sander CH, Kinnane L, Stevens NG. Hemorrhagic endovasculitis of the placenta: a clinicopathologic entity associated with adverse pregnancy outcome. Compr Ther. 1985;11:66–74
  32. Redline RW, Pappin A. Fetal thrombotic vasculopathy: the clinical significance of extensive avascular villi. Hum Pathol. 1995;26:80–85

 Cite this article as: Kovo M, Schreiber L, Ben-Haroush A, et al. Placental vascular lesion differences in pregnancy-induced hypertension and normotensive fetal growth restriction. Am J Obstet Gynecol 2010;202:561.e1-5.

 Authorship and contribution to the article is limited to the 6 authors indicated. There was no outside funding or technical assistance with the production of this article.

 The first 2 authors contributed equally to this article.

PII: S0002-9378(10)00023-2

doi: 10.1016/j.ajog.2010.01.012

American Journal of Obstetrics & Gynecology
Volume 202, Issue 6 , Pages 561.e1-561.e5 , June 2010